MENU

XRTX XORTX Therapeutics Inc. Forecast, Technical & Fundamental Analysis

XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease... Show more

XRTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
XRTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MB4.050.10
+2.53%
Masterbeef Group
ATPC1.550.01
+0.65%
Agape ATP Corporation
FNF40.620.12
+0.30%
Fidelity National Financial
PGNY28.44-0.14
-0.49%
Progyny
CAL12.72-0.23
-1.78%
Caleres

XRTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XRTX has been loosely correlated with BCDA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if XRTX jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRTX
1D Price
Change %
XRTX100%
-2.66%
BCDA - XRTX
43%
Loosely correlated
-5.54%
KPRX - XRTX
28%
Poorly correlated
+1.70%
BYSI - XRTX
26%
Poorly correlated
-5.13%
CLNN - XRTX
26%
Poorly correlated
+0.80%
MIST - XRTX
26%
Poorly correlated
-3.23%
More
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
3710 - 33rd Street NW
Phone
+1 403 455-7727
Employees
17
Web
https://www.xortx.com
XORTX Therapeutics (XRTX) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com